Search Results 2471-2480 of 20173 for Atrial

1. Fibromuscular Dysplasia Clinical Trials - Mayo Clinic Research

   To describe the clinical, laboratory, pathologic, imaging findings, therapy and outcomes in all patients with Fibromuscular Dysplasia (FMD) and/or segmental ...

2. A Study to Evaluate APR-246 & Azacitidine for the Treatment of TP53 Mutant Myelodysplastic Syndromes (MDS) - Mayo Clinic

   Symptomatic atrial or ventricular arrhythmias not controlled by medications;; QTc ≥ 470 msec (QT cardiac interval);; Bradycardia (< 40 bpm). Concomitant ...

3. Skull base tumors - Symptoms and causes - Mayo Clinic

   Skull base tumors are abnormal growths at the base of the skull that can be benign or cancerous and cause symptoms such as headaches, dizziness and ...

4. Mayo Clinic News Network Title: Robotic Mitral Valve Surgery / Date February 2015 Intro

   are to have heart failure, atrial fibrillation and die.” Dennis Douda speaking. Cardiac Surgeon Dr. Rakesh Suri says once the problem becomes severe ...

5. Lenalidomide (oral route) - Side effects & dosage - Mayo Clinic

   However, elderly patients are more likely to have blood clotting problems, heart rhythm problem (eg, atrial fibrillation), and kidney problems, which may ...

6. A Study To Assess Efficacy And Safety Of Baxdrostat In Participants With Primary Aldosteronism - Mayo Clinic

   * Persistent atrial fibrillation. * Treatment with any MRA or potassium-sparing diuretic within 2weeks prior to Randomisation. Note: Other protocol defined ...

7. Emergency Medicine - Doctors - Mayo Clinic

   Fernanda Bellolio, M.D., M.S.. Emergency Medicine Physician. Rochester, MN. Areas of focus: Heart attack, Atrial fibrillation, Croup, COPD, Pneumonia, Asthma ...

8. Blood Glucose and Blood Pressure Measurements Using a Wrist Wearable Sensor - Mayo Clinic

   Patients undergoing catheter ablation for atrial fibrillation. Exclusion Criteria: Patients unable to provide informed consent. Patients without arms as ...

9. AMBER-HFpEF: Assessment Of CK-4021586 In A Multi-Center, Blinded Evaluation Of Safety And Tolerability Results In HFpEF - Mayo Clinic

   * Screening NT-proBNP ≥ 300 pg/mL for participants in sinus rhythm and ≥ 900 pg/mL for participants with comorbid atrial fibrillation or flutter. * Body ...

10. Obese Adults with Cardiovascular Disease Evaluated in a Novel Cardiometabolic Clinic

    - At least one of the following CVD: atrial fibrillation (AF), coronary artery disease (CAD), HFpEF (heart failure with preserved ejection fraction), HFrEF ...